20 Jun 2011 07:00
20 June 2011 |
Surgical Innovations Group plc
("SI" or "the Group")
AGM Statement
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, will hold its Annual General Meeting today at 1.00 p.m. on 20 June 2011 at Clayton Wood House, 6 Clayton Wood Bank, Leeds LS16 6QZ. At the AGM the Chairman, Doug Liversidge CBE, will make the following statement:
"The Group has continued its progress with its own SI branded products and OEM customers in its core market of minimally invasive surgery. We have also continued our investment in manufacturing facilities and research and development capacity to keep up with the demand for our products, at the same time we are putting in place the platform for the Group's long term growth.
"Since the year end, we have successfully established new markets for the SI Brand in New Zealand and Saudi Arabia, as well as signing a new distributor in South Africa with one of the largest health insurers in the region. SI's flagship Resposable® product YelloPort+plus® continues to gain traction in the US and in Europe, while a number of new products are currently under development."
"The Group is currently trading in line with market expectations."
- Ends -
Enquiries:
Surgical Innovations Group plc
Doug Liversidge, Chairman
Graham Bowland, Chief Executive Officer Tel: +44 (0) 113 230 7597
graham.bowland@surginno.co.uk www.surginno.com
Seymour Pierce Limited
Freddy Crossley / Sarah Jacobs Tel: +44 (0) 20 7107 8000
Corporate Broking
Marianne Woods www.seymourpierce.com
Media enquiries:
The Communications Portfolio
Ariane Comstive / Caolan Mahon Tel: +44 (0) 20 7536 2028 / 2029
ariane.comstive@communications-portfolio.co.uk Mob: +44 (0) 7785 922 354
Notes to Editors:
About Surgical Innovations Group plc
Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets.
As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.
Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.
The Group's patented products are sold through three main channels:
SI brand | Through an established network of 45 distribution partners, Surgical Innovations branded products are sold in all major medical markets including North America, Europe, South Africa, the Middle East, South-east Asia and Australia. |
OEM | The Group supplies large medical device companies on an OEM basis, collecting sales fees as well as IP license and royalty fees. Clients include Teleflex Medical, Gyrus and CareFusion. |
Industrial
| SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, such as turbines, in situ with minimum disassembly and downtime. |
For more information, see www.surginno.com
Surgical Innovations (SUN)